Molecular Profiling of Response and Resistance to Venetoclax-Decitabine Therapy in Acute Myeloid Leukemia

被引：0
|
作者：
Khasawneh, Abdullah [1 ]
Paran, Faith Jessica [2 ]
Oyama, Rieko [2 ]
Maiti, Abhishek [3 ]
Abbas, Hussein A. [3 ,4 ]
Wang, Bofei [3 ]
Desai, Poonam N. [3 ]
Hayes, Kala [3 ]
Harman, Joe R. [5 ]
Su, Xiaoping [6 ]
DiNardo, Courtney D. [3 ]
Andreeff, Michael [7 ]
Milne, Thomas A. [5 ]
Konopleva, Marina Y. [3 ,8 ,9 ]
Tabe, Yoko [2 ,3 ,10 ]
机构：
[1] Juntendo Univ, Grad Sch Med, Dept Clin Lab Med, Bunkyo, Tokyo, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Res Support Utilizing Bioresource Bank, Tokyo, Japan
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX USA
[5] Univ Oxford, Radcliffe Dept Med, MRC Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford, England
[6] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX USA
[7] Univ Texas MD Anderson Canc Ctr, Sect Mol Hematol & Therapy, Dept Leukemia, Houston, TX USA
[8] Montefiore Med Ctr, Dept Oncol, Bronx, NY USA
[9] Albert Einstein Coll Med, Bronx, NY USA
[10] Juntendo Univ, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180463
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Abbreviated venetoclax with decitabine or azacitidine in acute myeloid leukemia
    Bouligny, Ian M.
    Murray, Graeme
    Ho, Thuy
    Doyel, Michael
    Patel, Tilak
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Wages, Nolan A.
    Grant, Steven
    Maher, Keri R.
    LEUKEMIA RESEARCH, 2023, 134
  • [2] Biomarkers of Response to Venetoclax Therapy in Acute Myeloid Leukemia
    Rodriguez-Medina, Carlos
    Stuckey, Ruth
    Bilbao-Sieyro, Cristina
    Gomez-Casares, Maria Teresa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [3] Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
    Bouligny I.M.
    Murray G.
    Doyel M.
    Patel T.
    Boron J.
    Tran V.
    Gor J.
    Hang Y.
    Alnimer Y.
    Ho T.
    Zacholski K.
    Venn C.
    Wages N.A.
    Grant S.
    Maher K.R.
    Medical Oncology, 41 (3)
  • [4] Molecular responses in decitabine- and decitabine/ venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromes
    Gruszczynska, Agata
    Maiti, Abhishek
    Miller, Christopher A.
    Ramakrishnan, Sai Mukund
    Link, Daniel C.
    Uy, Geoffrey L.
    Petti, Allegra A.
    Hayes, Kala
    Dinardo, Courtney D.
    Ravandi, Farhad
    Ley, Timothy J.
    Spencer, David H.
    Gao, Feng
    Konopleva, Marina Y.
    Welch, John S.
    HAEMATOLOGICA, 2024, 109 (08) : 2653 - 2659
  • [5] Venetoclax Resistance in Acute Myeloid Leukemia
    Garciaz, Sylvain
    Hospital, Marie-Anne
    Collette, Yves
    Vey, Norbert
    CANCERS, 2024, 16 (06)
  • [6] Molecular determinants of therapy response of venetoclax-based combinations in acute myeloid leukemia
    Makowka, Philipp
    Stolp, Verena
    Stoschek, Karoline
    Serve, Hubert
    BIOLOGICAL CHEMISTRY, 2021, 402 (12) : 1547 - 1564
  • [7] Venetoclax in combination with azacitidine or decitabine in relapsed/refractory acute myeloid leukemia
    Che, Yue
    Tan, Wanqing
    Liu, Ying
    Liu, Haitao
    Li, Lanlan
    Qin, Fangmei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) : 209 - 214
  • [8] Durable response with venetoclax in combination with decitabine or azacitadine in elderly patients with acute myeloid leukemia (AML).
    Dinardo, Courtney Denton
    Pratz, Keith William
    Potluri, Jalaja
    Pullarkat, Vinod A.
    Jonas, Brian Andrew
    Wei, Andrew H.
    Becker, Pamela Sue
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel Aaron
    Letai, Anthony G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Durable Response with Venetoclax in Combination with Decitabine or Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)
    DiNardo, Courtney D.
    Pratz, Keith
    Potluri, Jalaja
    Pullarkat, Vinod
    Jonas, Brian A.
    Wei, Andrew H.
    Becker, Pamela S.
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel A.
    Letai, Anthony
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S201 - S201
  • [10] Prognostic Value of CRh in Acute Myeloid Leukemia Treated with Venetoclax and Decitabine
    Siddiqui, Maria
    Maiti, Abhishek
    Daver, Naval
    Kadia, Tapan
    Rausch, Caitlin
    Alvarado, Yesid
    Ohanian, Maro
    Sasaki, Koji
    Short, Nicholas
    Takahashi, Koichi
    Yilmaz, Musa
    Ravandi, Farhad
    Kantarjian, Hagop
    DiNardo, Courtney
    Konopleva, Marina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S303 - S304
12345